Heron Therapeutics, Inc. (0J4V.L)

USD 1.62

(0.31%)

Inventory Summary of Heron Therapeutics, Inc.

  • Heron Therapeutics, Inc.'s latest annual inventory in 2023 was 42.11 Million USD , down -22.84% from previous year.
  • Heron Therapeutics, Inc.'s latest quarterly inventory in 2024 Q2 was 42.86 Million USD , up 0.92% from previous quarter.
  • Heron Therapeutics, Inc. reported annual inventory of 54.57 Million USD in 2022, up 12.8% from previous year.
  • Heron Therapeutics, Inc. reported annual inventory of 48.38 Million USD in 2021, up 15.46% from previous year.
  • Heron Therapeutics, Inc. reported quarterly inventory of 42.86 Million USD for 2024 Q2, up 0.92% from previous quarter.
  • Heron Therapeutics, Inc. reported quarterly inventory of 44.62 Million USD for 2023 Q2, down -14.28% from previous quarter.

Annual Inventory Chart of Heron Therapeutics, Inc. (2023 - 2012)

Historical Annual Inventory of Heron Therapeutics, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 42.11 Million USD -22.84%
2022 54.57 Million USD 12.8%
2021 48.38 Million USD 15.46%
2020 41.9 Million USD 67.83%
2019 24.96 Million USD -36.03%
2018 39.03 Million USD 286.15%
2017 10.1 Million USD 89.29%
2016 5.34 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of Heron Therapeutics, Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD -Infinity%
Dynavax Technologies Corporation 53.29 Million USD 20.98%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 45.6%
Perrigo Company plc 1.14 Billion USD 96.309%
Illumina, Inc. 587 Million USD 92.826%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.172%
Iovance Biotherapeutics, Inc. 10.37 Million USD -305.997%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.494%
IQVIA Holdings Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 98.368%
Unity Biotechnology, Inc. - USD -Infinity%
Waters Corporation 516.23 Million USD 91.843%
Biogen Inc. 2.52 Billion USD 98.334%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -282.888%
Adicet Bio, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 2.82 Million USD -1392.733%
bluebird bio, Inc. 22.91 Million USD -83.734%
Esperion Therapeutics, Inc. 65.62 Million USD 35.83%
FibroGen, Inc. 41.56 Million USD -1.311%
Agilent Technologies, Inc. 1.03 Billion USD 95.916%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 52.763%
Amicus Therapeutics, Inc. 59.69 Million USD 29.459%
Myriad Genetics, Inc. 20.1 Million USD -109.502%
Viking Therapeutics, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 98.358%
Abeona Therapeutics Inc. -2.44 Million USD 1822.995%
Mettler-Toledo International Inc. 385.86 Million USD 89.087%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 96.197%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 94.3%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -48.144%
Atara Biotherapeutics, Inc. 9.7 Million USD -333.855%
Verastem, Inc. - USD -Infinity%
Nektar Therapeutics 16.1 Million USD -161.537%
Axsome Therapeutics, Inc. 15.13 Million USD -178.229%
Aclaris Therapeutics, Inc. - USD -Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 86.957%
OPKO Health, Inc. 65.69 Million USD 35.903%
Exelixis, Inc. 17.32 Million USD -143.087%
Neurocrine Biosciences, Inc. 38.3 Million USD -9.948%
Corcept Therapeutics Incorporated 7.73 Million USD -444.761%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 12.02 Million USD -250.216%
Imunon, Inc. - USD -Infinity%
Blueprint Medicines Corporation 21.22 Million USD -98.417%
Insmed Incorporated 83.24 Million USD 49.416%
Halozyme Therapeutics, Inc. 127.6 Million USD 66.999%
Agios Pharmaceuticals, Inc. 19.07 Million USD -120.749%
TG Therapeutics, Inc. 39.82 Million USD -5.743%
Incyte Corporation 62.97 Million USD 33.129%
Emergent BioSolutions Inc. 328.9 Million USD 87.197%